510(k) K902220
K902220 is an FDA 510(k) premarket notification submitted by Boehringer Mannheim Corp. for the device "PRECIPATH(R) IM NORMAL & ABNORMAL IMMUNO. CONTROL". The FDA issued a decision of Substantially Equivalent on September 5, 1990. The device falls under product code DGR (Whole Human Serum, Antigen, Antiserum, Control), a Class I device regulated under 21 CFR 866.5700. Boehringer Mannheim Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 5, 1990
- Date Received
- May 17, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Whole Human Serum, Antigen, Antiserum, Control
- Device Class
- Class I
- Regulation Number
- 866.5700
- Review Panel
- HE
- Submission Type